Medicine Science (Sep 2017)

Cerebral venous thrombosis occurring during oxymetholone therapy

  • Gokce Pinar Reis,
  • Aysenur Bahadir,
  • Erol Erduran,
  • Tulay Kamasak,
  • Ilker Eyuboglu

DOI
https://doi.org/10.5455/medscience.2017.06.8618
Journal volume & issue
Vol. 6, no. 3
pp. 576 – 8

Abstract

Read online

Oxymetholone, an androgen analogue, is widely used in the treatment of Fanconi aplastic anemia (FAA). Androgen is known to cause cerebral venous thrombosis (CVT). A 9-year-old girl under monitoring with a diagnosis of FAA presented to our hospital with severe headache. She had been receiving oxymetholone therapy for 1 year. Neurological examination was normal. Superior sagittal sinus thrombosis was detected at magnetic resonance imagining (MRI) of the brain. The thrombosis was thought to be oxymetholone-related, and oxymetholone therapy was discontinued. The patient was started on enoxoparin therapy and the symptoms resolved. Control images 4 months later were normal. We think that the risk of venous thrombosis must be considered with administering oxymetholone therapy in patients with FAA. [Med-Science 2017; 6(3.000): 576-8]

Keywords